Prevalence and associated factors of metabolic syndrome in patients with schizophrenia: a multicenter cross-sectional study in China.

ABSTRACT: Metabolic syndrome (MetS) is highly prevalent among individuals with schizophrenia. However, substantial regional variation exists, and evidence from large samples of hospitalized patients in China remains limited. This study aimed to estimate the prevalence of MetS and to explore its associated factors among individuals with schizophrenia in China. We included 3042 participants with schizophrenia from 25 hospitals in Zhejiang Province from April to December 2022. MetS was defined according to the Chinese Diabetes Society (CDS) criteria, the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria, and the International Diabetes Federation (IDF) criteria. The prevalence of MetS was estimated using the Clopper-Pearson method, and generalized additive models w

SUBMITTER: Liao Z 

PROVIDER: S-EPMC12775019 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature